Bill with appropriate covered codes — non‑covered codes will be denied

When billing for laser therapy, providers must use the most appropriate procedure codes effective on the date of service; claims submitted for services that are not accompanied by covered code(s) under this policy will be denied as not covered.

• Use covered codes when criteria met (examples in policy coding: 97037, 0552T, S8948).
• Unlisted high‑power HILT should be reported with 97039 per policy coding guidance (97039 is considered experimental/investigational).

Prior authorization recommended — include diagnosis, prior conservative care, and laser parameters

When laser therapy is requested as a course of treatment, prior authorization should document the diagnosis, prior conservative therapies, and planned laser parameters and treatment schedule.

• Include diagnosis and reason for treatment.
• Describe prior/concurrent conservative treatments (e.g., exercise, splinting) and prior trial outcomes.
• Provide laser parameters (wavelength, joules per point, number/frequency of sessions) and planned schedule.

No specific prior authorization requirements specified in this excerpt

This excerpt does not specify mandatory prior authorization requirements or list payer-specific affected billing codes; check the applicable benefit plan or payer prior‑auth rules.

Prior authorization recommendation for PBM in oral mucositis — reference MASCC/ISOO protocols

For intraoral PBM/LLLT to prevent oral mucositis in patients undergoing HSCT or head & neck radiotherapy, documentation should reference MASCC/ISOO guideline‑recommended indication and protocols when seeking authorization.

• Document that treatment follows the MASCC/ISOO intraoral PBM protocol for OM prevention.
• Specify patient population (HSCT or head & neck RT with/without chemotherapy) and cite the guideline recommendation.

Device/indication prior authorization — provide device model and 510(k) info

If a payer requires prior authorization for use of a specific laser device, provide the device model, FDA 510(k) clearance information, indication, treatment parameters, and supporting clinical evidence.

• Include device model and FDA 510(k) clearance summary or documentation.
• Provide indication‑specific rationale and cited clinical evidence supporting use for that indication.

No prior authorization statements in references section

No prior authorization statements are included in the references section of this policy excerpt.

No prior authorization requirements in reference‑only chunks

The reference‑only chunks do not specify prior authorization requirements.

Require trial of conservative therapy before laser authorization

Consider documenting trials of standard conservative care (e.g., exercise therapy, splinting for CTS, education/self‑management for lumbar disc herniation) prior to authorization of laser therapy, since most evidence evaluates laser as an adjunct to these treatments.

• Document duration and response to conservative therapies.
• Note concurrent rehabilitation or exercise programs when laser is used as an adjunct.

Stepwise care for chronic TMD — document first‑line conservative treatments first

For chronic temporomandibular disorder (TMD), guideline panels recommend first‑line conservative treatments (e.g., CBT, supervised jaw exercise, occlusal splints) before interventions that received conditional recommendations against them; document prior use of recommended conservative therapies if requesting laser treatment.

• Document use and outcomes of first‑line therapies (CBT, exercise, splints) prior to considering LLLT.

Document prior conservative care for musculoskeletal indications

For musculoskeletal conditions, document prior conservative care such as exercise or multimodal rehabilitation because reviews recommend laser therapy be considered as part of a multimodal approach.

• Specify type and duration of prior rehabilitation or exercise program and patient response.
• Indicate whether laser is intended as an adjunct to ongoing multimodal therapy.

References do not add extra provider actions

References cited in this section do not specify additional operational provider actions beyond those already stated.

No step therapy requirements specified in references

No step therapy requirements are specified in the referenced chunks.

Required documentation elements — diagnosis, parameters, pre/post observations, outcomes

Documentation should include the diagnosis/reason for treatment, duration and specific laser parameters used, area treated, observations pre‑ and post‑treatment, and demonstration of improvement or lack thereof to support medical necessity.

• Record treatment dates, number and frequency of sessions, and objective/subjective outcome measures.
• Include pre/post observations and functional change documentation.

Document clinical details — diagnosis, rehab, and exact laser parameters

Recommended clinical documentation should include diagnosis, prior or concurrent exercise/rehabilitation when applicable, specific laser parameters (wavelength, joules per point, number and frequency of sessions), and follow‑up outcomes because efficacy is often dose‑ and protocol‑dependent.

• Specify wavelength and joules per point (e.g., LLLT 4–8 J per point for KOA where cited).
• Include number of sessions and frequency (e.g., 10–16 sessions at ~2/wk for KOA studies).

Protocol adherence and informed consent for PBM in OM prevention

If providing PBM/LLLT for prevention of oral mucositis, clinicians should follow the PBM protocols described in the MASCC/ISOO guidelines and document informed consent noting expected benefits and any tumor‑related uncertainties.

• Document adherence to MASCC/ISOO intraoral PBM protocol.
• Obtain and document informed consent discussing benefits and uncertainties.

Document laser protocol parameters (wavelength, fluence, site, frequency) and cite sources

Document adherence to published PBMT/LLLT parameter protocols (wavelength, fluence/energy, treatment site, and frequency) and cite guideline or WALT sources when applicable, since adherence to recommended dosages is associated with better outcomes.

• Record wavelength, energy per point, power density, and number/frequency of applications.
• Cite WALT or guideline‑consistent dosing where used.

References-only chunks — no additional documentation requirements

Reference sections do not add operational documentation requirements beyond those already specified.

Reference list — no operational documentation requirements

Reference list chunks do not specify operational documentation requirements for providers.

Claims without covered codes will be denied

Claims submitted for services that are not accompanied by covered code(s) under this policy will be denied as not covered.

Inadequate/undefined dosing or missing parameter documentation risks denial

Trials performed with inadequate laser doses were ineffective; unclear or suboptimal dosing or omission of parameter documentation may lead to lack of benefit and potential denial risk if parameter details are not provided.

• Ensure documentation includes dosimetry (e.g., joules per point) and adherence to recommended dosing when applicable.
• Note that studies noted ineffective results when inadequate doses were used.

No explicit authorization or denial triggers in these chunks

Not applicable in this excerpt — no explicit authorization or denial triggers are stated in these reference chunks.

Guideline‑based denial risk for chronic TMD

Guideline panels issued conditional recommendations against low‑level laser therapy (alone or in combination) for chronic TMD pain, indicating use for chronic TMD may be at higher risk for noncoverage or denial in some contexts.

• Document prior first‑line treatments and rationale if requesting LLLT for chronic TMD.

Evidence/device limitations may increase denial risk

Use of devices or treatments without demonstrated peer‑reviewed evidence of benefit, or use outside accepted protocols, may be at risk for noncoverage given variable evidence and FDA 510(k) approvals based on summaries rather than published trials.

• Provide peer‑reviewed evidence when requesting coverage for a specific device/indication.
• If device evidence is limited to 510(k) summaries, anticipate heightened scrutiny.

Reference sections — no operational provider requirements

Reference sections list citations only and do not state operational authorization requirements.

Reference‑only chunks — no provider authorization requirements

Reference list chunks do not state provider authorization requirements.